WO2024112298 - A TABLET COMPRISING TERIFLUNOMIDE
National phase entry is expected:
Publication Number
WO/2024/112298
Publication Date
30.05.2024
International Application No.
PCT/TR2023/051353
International Filing Date
20.11.2023
Title **
[English]
A TABLET COMPRISING TERIFLUNOMIDE
[French]
COMPRIMÉ COMPRENANT DU TÉRIFLUNOMIDE
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
ATAK, Fadime Bilgehan
ATAMAN, Seval
ERİS, Duygu
YAZICI, Ozlem
SARP, Onder
Priority Data
2022/017840
25.11.2022
TR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1956 | |
| EPO | Filing, Examination, Granting | 9157 | |
| Japan | Filing, Examination, Granting | 1998 | |
| South Korea | Filing, Examination, Granting | 1804 | |
| USA | Filing, Examination, Granting | 4740 |

Total:
19,655
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a film coated tablet comprising teriflunomide, wherein the tablet comprising calcium stearate as lubricant and teriflunomide has a d (0.5) particle between 1 µm and 18 µm. Further the present invention discloses a method for the preparation of said tablet.[French]
La présente invention concerne un comprimé pelliculé comprenant du tériflunomide, le comprimé comprenant du stéarate de calcium en tant que lubrifiant et le tériflunomide ayant une taille de particule d (0,5) comprise entre 1 µm et 18 µm. La présente invention concerne en outre un procédé de préparation dudit comprimé.